Access to Medicines and the Financing of Innovations in Health Care
Hosted by
The Program on Science, Technology, and Global Development
The Earth Institute at Columbia University
and the
Consumer Project on Technology, Washington D.C.
December 4th, 2003
569 Lerner Hall, Columbia University
Can we promote "access for medicines" to all, and finance faster, more appropriate innovation in health care?
8:45 to 9:00 Welcome and Introductions
Jeffrey Sachs
9:00 to 10:00 Proposals to Address Market Failures in R&D I
Richard Nelson, Moderator
Henry Grabowski, "Innovation and R&D Incentives for Orphan Drugs and Neglected Diseases"
James Love, "A New Global Framework for Funding R&D" (PDF) (PPT presentation)
Discussion
10:15 to 11:15 Proposals to Address Market Failures in R&D II
Will Masters, Moderator
Tim Hubbard, "Four Alternatives to the Price System"
Jerome Reichman and Tracy Lewis, "Liability Rules and R&D Investment"
Discussion
11:15 to 12:30 Discussion of Current Proposals: Clarification and Reactions
Sakiko Fukuda-Parr, Moderator
Bruce Lehman, "The Pharmaceutical Industry and the Patent System"
Spring Gombe, "Good Money After Bad: Access to Health and Financing R&D"
Brandon Lerch
Discussion
12:30 to 1:30 Lunch Break
1:30 to 2:30 Costs of Patent Protection and Benefits of Innovation
Juan Rovira, Moderator
Frank Lichtenberg, "The Economic Benefits of Medical Innovation"
Andrew Farlow, "Costs of Monopoly Pricing Under Patent Protection"
Shubham Chaudhuri, "Estimating the Effects of TRIPS in India"
Discussion
2:30 to 3:30 R&D As a Global Good
James Orbinski, Moderator
Robert Weissman, "R&D in International Treaties"
Nicoletta Dentico, "Lessons from the Tobacco Control and Landmine Conventions"
Amy Kapczynski, "Best Practices for Management of Publicly Funded R&D"
Discussion
4:00 to 5:00 Open Discussion: Priority-setting for Analysis and Advocacy
Richard Nelson and James Love, Moderators
5:00 to 5:30 Wrap-up: Where Do We Go From Here?
Jeffrey Sachs